Key Decisions for Life Science Companies: Stay the Course or Exit via M&A?
By , , ,

This article is the fourth in a 4-part series reviewing financing solutions for the Life Science sector. Many life science companies are fortunate to reach a critical inflection point where leadership must face a decision: continue to fund growth to reach clinical milestones independently or exit via merger and acquisition….Read More

Read More
Creative Financing Approaches in Life Science
By , , ,

This article is the third in a 4-part series reviewing financing solutions for the Life Science sector. As Life Science company valuations have fluctuated significantly over the last two years, and investors have become cautious due to economic turbulence and market uncertainty, fundraising is taking longer. Equity financing has been…Read More

Read More
CEO Advice: How to Select the RIGHT Interim CFO
By

FLG Partners is a leading solution for CEOs, boards and management teams when it comes to sourcing experienced interim CFO talent. Whether your company is a small, publicly traded biotech preparing to raise its next equity financing or a large multi-national firm in need of restructuring, margin improvement and cash…Read More

Read More
Fundraising Choices in Life Sciences: What, When & Why?
By

This article is the second in a two-part series about fundraising strategies for life science companies. In our last article, A Menu of Financing Alternatives for Life Science Companies, we looked at the continuum of choices available to life science companies who are actively engaged in fundraising to power up…Read More

Read More

More Posts